Wosulin 50/50 Dispo Pen 2 is a pre-filled insulin pen containing a biphasic mixture of insulin isophane (50%) and human insulin (50%), designed for the management of diabetes mellitus requiring insulin therapy. This combination provides both intermediate-acting and short-acting insulin components, facilitating improved glycemic control by addressing both basal and prandial insulin needs. Insulin isophane, the intermediate-acting component, ensures a prolonged duration of action to maintain baseline insulin levels, while the human insulin component offers rapid onset to manage postprandial glucose excursions. Wosulin 50/50 Dispo Pen 2 is indicated for adult patients with type 1 and type 2 diabetes who require insulin for optimal glycemic regulation. The disposable pen device allows for accurate dosing, ease of use, and enhanced patient compliance. Dosage and administration should be individualized based on patient-specific factors including blood glucose monitoring results, dietary intake, and physical activity. Patients should be educated on proper injection techniques, storage conditions, and recognition of hypoglycemia. As with all insulin products, careful monitoring is essential to minimize the risk of hypoglycemia and other adverse effects. Wosulin 50/50 Dispo Pen 2 should be used under medical supervision as part of a comprehensive diabetes management plan.